- Home
- LSTA vs ENZ Comparison
LSTA vs ENZ Comparison
Compare LSTA & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- ENZ
- Stock Information
- Founded
- LSTA 1980
- ENZ 1976
- Country
- LSTA United States
- ENZ United States
- Employees
- LSTA N/A
- ENZ N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- ENZ Medical Specialities
- Sector
- LSTA Health Care
- ENZ Health Care
- Exchange
- LSTA Nasdaq
- ENZ Nasdaq
- Market Cap
- LSTA 31.2M
- ENZ 34.2M
- IPO Year
- LSTA N/A
- ENZ N/A
- Fundamental
- Price
- LSTA $2.55
- ENZ $0.52
- Analyst Decision
- LSTA Strong Buy
- ENZ
- Analyst Count
- LSTA 1
- ENZ 0
- Target Price
- LSTA $15.00
- ENZ N/A
- AVG Volume (30 Days)
- LSTA 24.3K
- ENZ 178.2K
- Earning Date
- LSTA 02-27-2025
- ENZ 03-12-2025
- Dividend Yield
- LSTA N/A
- ENZ N/A
- EPS Growth
- LSTA N/A
- ENZ N/A
- EPS
- LSTA N/A
- ENZ N/A
- Revenue
- LSTA N/A
- ENZ $30,314,000.00
- Revenue This Year
- LSTA N/A
- ENZ N/A
- Revenue Next Year
- LSTA N/A
- ENZ N/A
- P/E Ratio
- LSTA N/A
- ENZ N/A
- Revenue Growth
- LSTA N/A
- ENZ N/A
- 52 Week Low
- LSTA $2.19
- ENZ $0.41
- 52 Week High
- LSTA $4.20
- ENZ $1.40
- Technical
- Relative Strength Index (RSI)
- LSTA 42.39
- ENZ 36.14
- Support Level
- LSTA $2.41
- ENZ $0.46
- Resistance Level
- LSTA $2.66
- ENZ $0.57
- Average True Range (ATR)
- LSTA 0.19
- ENZ 0.05
- MACD
- LSTA 0.01
- ENZ 0.00
- Stochastic Oscillator
- LSTA 42.06
- ENZ 53.20
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.